COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Indego Exoskeleton After SCI

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02793635
Recruitment Status : Completed
First Posted : June 8, 2016
Last Update Posted : August 31, 2018
Information provided by (Responsible Party):
Parker Hannifin Corporation

Brief Summary:

The purpose of this study is to assess the use of Indego as a gait training tool for subjects with complete or incomplete paraplegia as a result of spinal cord injury (SCI) who have preserved lower extremity function. It is hypothesized that subjects with complete or incomplete paraplegia who have preserved their lower extremity function will experience functional improvements after gait training with the Indego exoskeleton.

Subjects will complete a total of fifteen (15) sessions which include a combination of the following; Physical Therapy Evaluation, Indego Training, Mid-Way Assessment, and Post-Assessment.

The aim of this study is to measure the impact of gait training with the Indego device on body structure, function, and participation. Additionally it will assess the perceptions of physical therapists and subjects with SCI on the effectiveness of gait training with the Indego exoskeleton in subjects with preserved limited function.

Condition or disease Intervention/treatment Phase
Spinal Cord Injury Device: Indego Powered Exoskeleton Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 9 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Impact of Gait Training With an Exoskeleton on Walking Function After Spinal Cord Injury (SCI)
Study Start Date : June 2016
Actual Primary Completion Date : March 2018
Actual Study Completion Date : March 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: SCI Patients
  • 10 subjects with complete or incomplete SCI (> 1 year post-injury) with preserved LE function will be recruited.
  • No control group
Device: Indego Powered Exoskeleton
Subjects who have Spinal Cord Injury will wear the Indego device which will include being trained and evaluated for fifteen (15) sessions.
Other Name: Vanderbilt exoskeleton

Primary Outcome Measures :
  1. Functional ambulation category (FAC) to measure gait quality [ Time Frame: 1 Day ]
    Categorizes patients according to basic motor skills necessary for functional ambulation

  2. 10 Meter Walking Test to measure fast gait speed [ Time Frame: 1 Day ]
    Assesses walking speed in meters per second over a short duration

  3. 6 Minute Walking test to measure endurance [ Time Frame: 6 Minutes ]
    Measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18 years or older
  • Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length)
  • Weight 250 lbs or less
  • Present with paraplegia resulting from a complete or incomplete (AIS A, B, C, or D) Spinal Cord Injury (>1 year post-injury), with preserved LE function
  • Uses wheelchair as primary means of mobility in the community
  • Able to ambulate 14 meters with assist of 2 people and no orthostasis. Subjects may use any combination of stability aids and/or bracing.
  • Medical clearance for weight bearing and locomotor training

    • Bone density exams will be at the discretion of each sites' Principle Investigator
  • Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within functional limits for safe gait and use of appropriate assistive device/stability aid
  • Skin intact where interfaces with the Indego device
  • Modified Ashworth Scale 3 or less in bilateral LEs
  • Blood pressure and heart rate within Locomotor Training Guidelines

    • At rest: Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
    • Exercise: Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less

Exclusion Criteria:

  • Inability to meet ALL inclusion criteria
  • Currently participating in physical therapy for gait training
  • Joint contractures of the shoulders, trunk, hips knees or ankles deemed unsafe for locomotor training by PT and or MD
  • Edema that would put skin at risk for breakdown
  • Modified Ashworth Spasticity of 4
  • Inability to achieve adequate fit of the Indego device
  • Pregnancy
  • Colostomy bag

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02793635

Layout table for location information
United States, New York
St. Charles Hospital
Port Jefferson, New York, United States
United States, Texas
TIRR Memorial Hermann
Houston, Texas, United States, - TIRR Memorial Hermann,
United States, Virginia
Sheltering Arms
Mechanicsville, Virginia, United States, 23116
Sponsors and Collaborators
Parker Hannifin Corporation
Layout table for additonal information
Responsible Party: Parker Hannifin Corporation Identifier: NCT02793635    
Other Study ID Numbers: 15-01399
First Posted: June 8, 2016    Key Record Dates
Last Update Posted: August 31, 2018
Last Verified: August 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Parker Hannifin Corporation:
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Wounds and Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System